EW
Edwards Lifesciences Corporation
NYSE · Healthcare · Medical - Devices · US
$89.80
+0.02%Aug 28, 2026, 20:20 UTC
Donald E. Bobo, Jr. retired as Corporate Vice President of Strategy and Corporate Development at Edwards Lifesciences Corp.
Aug 23, 2026, 08:30 UTC
EP Wealth Advisors LLC acquired a new position in Edwards Lifesciences Corporation by purchasing 37,702 shares valued at approximately $3,410,000, as disclosed in a recent SEC filing.
Source:Aug 22, 2026, 07:57 UTC
B. Metzler seel. Sohn & Co. AG acquired a new position of 41,753 shares in Edwards Lifesciences Corporation during the second quarter, valued at approximately $3,777,000.
Source:Aug 22, 2026, 07:11 UTC
Allworth Financial LP acquired a new position in Edwards Lifesciences Corporation, buying 16,600 shares valued at approximately $1,502,000 during the second quarter, as disclosed in a 13F filing.
Source:Aug 17, 2026, 08:33 UTC
Baxter Bros Inc. disclosed a new minority stake in Edwards Lifesciences Corporation, purchasing 39,184 shares valued at approximately $3.54 million during the undefined quarter.
Source:Jul 24, 2026, 00:30 UTC
The FTC secured $12 million in penalties from Edwards Lifesciences Corp. and Genesis MedTech Group Limited for failing to make a Hart-Scott-Rodino filing.
Source:Jul 23, 2026, 20:15 UTC
Edwards Lifesciences reported financial results for the second quarter ended June 30, 2026, with sales of $1.74 billion and EPS of $0.42.
Jul 16, 2026, 04:29 UTC
Jenscare Scientific's LuX-Valve Plus system completed the first patient implantations in the FDA-approved pivotal clinical trial in the United States.
Source: